Typical atrioventricuiar (AV) nodal reentry tachycardia (AVNRT) is characterized by anterograde activation over a slowly conducting pathway and by retrograde activation through a rapidly conducting pathway. Preliminary reports suggest that radiofrequency catheter modification can eliminate typical AVNRT while preserving anterograde conduction. Radiofrequency catheter modiication was used to treat 66 patients with typical AVNRT. After baseline electrophysiologic evaluation, the ablation catheter was positioned proximal and superlor to the site of maximal His deflection. Radiofrequency energy was applied until there was significant attenuation of retrograde conduction, and elimination of AVNRT inducibility. Eighty-one patients were successfully treated and form the basis of this report.
T achycardia due to atrioventricular (AV) nodal reentry (AVNRT) needs 2 nodal or perinodal pathways, differentiated on the basis of their relative conduction times.' Typical AVNRT is characterized by anterograde conduction over the "slow" pathway and by retrograde conduction over the "fast" pathway, and accounts for approximately 50% of patients with paroxysmal supraventricular tachycardia. Atypical AVNRT, in which there is retrograde conduction over the slow pathway, and anterograde conduction over the fast pathway, is much less frequent, accounting for < 1% of paroxysmal supraventricular tachycardias in most series.2~3 Preliminary reports suggest that catheter modification of the AV node using radiofrequency energy can eliminate AVNRT while preserving anterograde conduction.4-6 However, the anatomic substrate for nodal reentry remains incompletely defined. This report describes the occurrence of a new type of tachycardia after successful ablation of typical AVNRT. This tachycardia has the appearance of atypical AVNRT, with a PR interval shorter than the RP interval. The characteristics and clinical significance of this "atypical" tachycardia, and the possible mechanisms by which it occurs are described.
METHOD9
Patients and ablative procedure: Between August 1989 and November 1990, 88 patients (29 men and 59 women, mean age 50 f 18 years) were referred to the University of Michigan Medical Center for treatment of typical AVNRT. This cohort was described in part in previous reports.4J Patients had been symptomatic for a mean of 18 f 13 years. The ablation procedure was approved by the institutional review board, and all patients gave informed, written consent. All patients underwent a baseline electrophysiologic test to define anterograde and retrograde AV conduction and refractoriness, and to confirm the presence of typical AV nodal reentry tachycardia, using previously described techniques7 The following criteria were sought to support the diagnosis of AV nodal reentry: (1) tachycardia induction associated with a critical degree of prolongation of the atrial-His (AH) interval, and (2) atria1 activation during tachycardia that was coincident with or closely (<50 ms) followed ventricular activation. Other findings suggestive of AVNRT were the presence of dual AV nodal physiology (discontinuous AV nodal function curves) and tachycardia termination with a premature ventricular complex that did not result in activation of the atria. An electrode catheter was not introduced into the coronary sinus, and detailed mapping of the sequence of retrograde activation was not performed. No patient had atypical AV nodal reentry induced before catheter ablation.
The technique for catheter ablation, as previously described," was performed with an electrosurgical unit (Radionics RFG 3-B, Watertown, MA) that delivered a constant, unmodulated sine wave output at 350 kHz. A large-tip (3 or 4 mm in length) electrode catheter was positioned slightly proximal and superior to the site of the maximal His bundle deflection. Recordings from the ablation site typically had an atrial-to-ventricular electrogram ratio L 1, and a His amplitude <lOO pV. A mean of 14 f 5 W of radiofrequency power was applied between the distal electrode of the ablation catheter and an indifferent skin electrode. Ablation was continued until there was >50% prolongation in the PR interval or aVF ventriculoatrial conduction time, or both, and typical AVNRT could no longer be induced.
Eighty-one patients had a successful outcome, defined as persistent elimination of typical AVNRT inducibility with preservation of AV conduction, and form the basis of this report. After a successful ablation, electrophysiologic testing was performed before and during isoproterenol infusion at a dose sufficient to increase the heart rate by 120%. Complete electrophysiologic testing with evaluation of AV conduction was repeated 2 to 4 days and again at 3 months after the ablation procedure in all patients. At follow-up testing, patients who had a new supraventricular tachycardia characterized by an AH < the His-atria1 (HA) interval were considered to have "atypical" tachycardia. Patients with atypical supraventricular tachycardia induced after ablation had complete electrophysiologic evaluations aimed at characterizing the arrhythmia mechanism, including both atria1 and ventricular extrastimulus testing during tachycardia.
Data analysis: Results are expressed as mean f 1 standard deviation. Characteristics of patients with and without atypical tachycardia were compared by analysis of variance and chi-square analysis. The Student's t test for paired data was used to compare features of supraventricular tachycardia and AV nodal function before and after ablation. A p value <0.05 was considered significant.
RESULTS
Nine of 8 1 (11%) patients successfully treated with radiofrequency catheter ablation had new, "atypical" AV nodal reentry induced during the follow-up electrophysiologic study ( Figure 1 ). The arrhythmia was induced immediately after radiofrequency modification in 3 patients and at the early (2 to 4 days) restudy in 4. Atypical tachycardia was induced for the first time at the late (3 months) follow-up test in 3 patients. There were no differences in mean age, sex distribution and duration of symptoms between patients with (group I) and without (group II) atypical AV nodal reentry after ablation (Table I) .
Electrophysiologic characteristics of atypical supraventricular taehycardii induced during follow-up evaluation: In all group I patients, atypical supraventricular tachycardia was induced only by ventricular overdrive pacing or programmed stimulation, or both, during isoproterenol infusion ( Figure 2 ). Single atypical echo beats were induced in only 1 patient in the baseline state during ventricular extrastimulation. Initiation of the tachycardia appeared to be dependent on achieving a critical degree of delay in retrograde conduction. In 4 patients, new retrograde dual AV nodal physiology (defined as 250 ms increase in ventriculoatrial activation time after 10 ms decrease in the coupling interval of the ventricular extrastimulus) was observed after ablation ( Figure 3 ). In distinct contrast to the baseline findings before ablation, none of these patients had supraventricular tachycardia induced with atria1 overdrive pacing or extrastimulation. Characteristics of the arrhythmia are summarized in Table II . Mean tachycardia cycle length was 357 f 51 ms. Mean AH activation time was 140 f 31 ms, and ventriculoatrial time was 170 f 46 ms. During ventricular pacing, retrograde conduction was decremental and atria1 septal activation preceded high right atria1 activation in all cases. Tachycardia was reproducibly terminated with ventricular overdrive pacing in 7 of 9 patients. In 1 patient, a ventricular premature stimulus interrupted the tachycardia without subsequent retrograde atria1 activation, and in another, spontaneous termination of the arrhythmia after atria1 activation was seen.
AV nodal function in group 1 during isoproterenol infusion before and after ablation at the time of induction of atypical AV nodal reentry are compared in Table II. As with the overall population, radiofrequency ablation produced an increase in the AH interval in sinus rhythm from 69 f 12 to 147 f 26 ms. Despite the increase in conduction time, there was no change in anterograde AV Wenckebach block cycle length. In contrast, retrograde conduction was significantly attenuated, as reflected by an increase in the ventriculoatrial block cycle length from 257 f 32 to 344 f 47 ms (p <O.Ol). The AH interval during atypical AV nodal reentry was a mean of 67 ms < AH during atria1 overdrive pacing at a comparable cycle length of 350 ms.
Comparison of patients with and without atypical atrioventricular nodal reentrant tadmycardh: The cycle length of AVNRT induced during the baseline electrophysiologic test was shorter for group I (314 f 40 ms) than II (387 f 77 ms; p = 0.02). Anterograde and retrograde AV nodal Wenckebach cycle lengths and the frequency of anterograde dual AV nodal physiology were the same for both groups (Table I) .
The number of radiofrequency applications, and the mean voltage, current and duration of each applica- Table I. tion were similar for the 2 groups (Table III) . The amplitudes of the atrial, His and ventricular electrograms at the site resulting in successful ablation of typical AVNRT were also similar for the 2 groups.
Atrioventricular nodal function in patients with and without atypical reentry after successful modification are compared in Table IV . There were no differences in anterograde or retrograde block cycle lengths or effective refractory periods between the 2 groups. Retrograde conduction was present in all 9 patients in group I, and in 37 of 72 in group II (p = 0.0006). There was a trend toward shorter ventriculoatrial conduction times at a paced cycle length of 400 ms in group I than in II (162 f 10 vs 247 f 62 ms; p = 0.066). Anterograde dual AV nodal physiology was not seen in any group I patient and was present in 9 group II patients after suc- 400 cessful modification (p = not significant). New retrograde dual physiology occurred in 4 group I and in 2 group II patients (p = 0.0001) after the procedure.
Follow-up of patients with atypical atrioventricular nodal reentrant tachycardia:
No patient with atypical AVNRT after ablation received antiarrhythmic therapy or additional ablation sessions. One patient developed a spontaneous, sustained episode of atypical AVNRT 4 weeks after ablation. Therapy with verapamil (240 mg/day) was initiated, but was discontinued after 2 months because of intractable side effects. Repeat electrophysiologic testing at that time showed no retrograde conduction or inducible tachycardia before or during isoproterenol infusion. This patient has been free of arrhythmia recurrence for 13 months without therapy.
The remaining 8 patients have been followed for 12 f 3 months. None have had symptomatic tachycardias. None of the 6 patients who had atypical AVNRT during their initial hospitalization (either immediately after modification or at the early restudy) had inducible tachycardia at the time of late restudy (3 months). Retrograde conduction was no longer present in 3 of these patients during the late restudy.
DISCUSSION
Main findings: A new paroxysmal supraventricular tachycardia with a long RP interval was induced after successful radiofrequency catheter ablation of typical AVNRT in 9 of 81 (11%) patients. The baseline cycle length of the typical AVNRT was slightly shorter in patients who went on to develop atypical tachycardia than in those who did not. Otherwise, there were no differences in baseline clinical, electrophysiologic or ablation parameters between the 2 groups.
Atypical tachycardia was inducible only by ventricular pacing during isoproterenol infusion and appeared to be mediated by AV nodal reentry. New retrograde dual AV nodal physiology was more frequent in patients with atypical reentry than in those without tachycardia after ablation. Although no patient was treated with antiarrhythmic medications, only 1 of 9 had an episode of spontaneous atypical tachycardia during a mean fol- Tables I and II, low-up of 12 months. Therefore, induction of atypical AV nodal reentry after radiofrequency ablation of typical AVNRT appears to be of little clinical significance.
Comparison with previous studies: Several features of this novel arrhythmia suggest that it was mediated by AV nodal reentry rather than atria1 tachycardia or an accessory AV connection. The tachycardia was reproducibly induced with critically timed ventricular extrastimulation, as has been described in patients with spontaneous retrograde dual AV nodal physiology.8 Termination of the tachycardia with a ventricular premature beat that did not excite the atrium excludes its participation in the reentry circuit. Spontaneous termination after atria1 activation also argues against an atria1 arrhythmia. There was no evidence of extranodal accessory AV connections, with decremental retrograde atria1 activation in all cases.
Haissaguerre et al9 recently described the follow-up of 42 patients after direct-current shock ablation for AV nodal reentry. Four of 26 patients (15%) undergoing late (4.7 f 6 months after ablation) electrophysiologic testing had single atypical AV nodal echo beats induced. Apparently none of these patients had sustained tachycardia, but it is not clear how many had repeat testing during isoproterenol infusion.
Observations relating to the site of ablative injury:
Several features of patients who developed atypical AVNRT may have implications relevant to the location of ablative injury. The AH interval during atria1 pacing was markedly prolonged after ablation. In contrast, the AH interval during atypical AVNRT was relatively short. The AH interval during atria1 pacing is the sum of conduction times in the proximal common pathway and the AV node itself, whereas during tachycardia, the AH interval is the difference between these conduction times. lo Therefore, the conduction delay that was present during atria1 pacing was due to slowing proximal to the reentry circuit in the upper common pathway (Figure 4A ). This evidence of an upper common pathway strongly suggests that atria1 tachycardia was not responsible for the atypical tachycardia induced after ablation.
Anterograde AV nodal block cycle length and refractoriness did not change despite the marked increase in conduction time. A similar pattern was observed in an animal study when ablative injury involved the approaches to the node with relative sparing of the more distal NH region." Some animals in that study had progressive attenuation of AV nodal function in the weeks after ablation, presumably as the result of fibrosis and scar formation. A similar process may account for the loss of retrograde conduction in 4 of 9 patients with atypical AV nodal reentry early after ablation.
Possible mechanisms of atypical reentry after abfation: Possible mechanisms for reentry after ablation are diagrammed in Figure 4 . The arrhythmia may represent the original, typical AV nodal reentry with superimposed proximal common pathway delay. Although retrograde conduction in the reentry circuit remains fast, slow conduction in the proximal common pathway would produce a long ventriculoatrial interval. This mechanism seems unlikely because it does not account for the significant slowing of tachycardia rate after ablation and for the inducibility of paroxysmal supraventricular tachycardia by ventricular pacing after ablation but not at baseline.
Ablative injury may have resulted in prolongation of refractoriness in the fast pathway. This could allow selective retrograde block in the fast pathway during ventricular pacing and initiation of atypical AVNRT (retrograde conduction through the slow pathway, and anterograde over the fast pathway). The trend toward a shorter ventriculoatrial time at slower paced rates, and the emergence of retrograde dual AV nodal physiology in 4 of 9 patients is consistent with this hypothesis. The disappearance of retrograde conduction in 4 patients who initially had atypical tachycardia also supports the notion that it was mediated by a damaged fast pathway. An ablation-induced increase in fast pathway conduction time could account for many of the observations. Although the circuit would be the same as before ablation, retrograde activation would be delayed. The resultant slowing in tachycardia rate might be expected to shorten anterograde conduction time and the AH interval.
Finally, destruction of the fast pathway might unmask a third pathway capable of mediating retrograde conduction, albeit more slowly. Triple pathways have been described,i2,i3 and such a pathway may be concealed during the baseline evaluation. McGuire et alI4 recently described a small cohort of patients with 2 types of AV nodal reentry. In addition to typical AV node reentry, they also had a second type of tachycardia with earliest atria1 activation near the OS of the coronary sinus. As with the patients in the current study, the atypical reentry was characterized by a slower rate, shorter AH intervals and longer ventriculoatrial activation time. They hypothesized that these patients had 2 slow AV nodal pathways located posteriorly, 1 of which was capable of serving at the retrograde limb of a "slow-slow" tachycardia circuit ( Figure 3B ). This study is limited by the absence of coronary sinus recordings or retrograde activation times from other sites on the interatrial septum. These data may have clarified whether the atypical reentry was mediated by pathways that were anatomically distinct from those responsible for the initial, typical tachycardia.
Clinical implications:
Previous reports of patients treated by either catheter4-6J6 or operativei7m18 ablation noted control of AVNRT despite persistence of retrograde AV nodal conduction, dual AV nodal physiology and AV nodal echo beats. The results of this study confirm that typical AVNRT can be rendered noninducible without complete destruction of intra-or perinodal reentrant pathways.
Elimination of typical AVNRT was the end point for radiofrequency catheter modification of the AV junction in this series. More than 10% of patients deemed successfully treated had atypical reentry induced after ablation. Sustained tachycardia could only 1 be induced during isoproterenol infusion owing to significant attenuation of retrograde conduction. This may account for the low incidence of spontaneous atypical reentry and suggests that induction of this tachycardia should not be an indication for additional ablation sessions or long-term antiarrhythmic therapy.
